Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Patentable Subject Matter In Bioinformatics After USPTO’s January Guidance: Easier To Obtain, But Harder To Keep

    Bio-IT World Contributed Commentary | The United States Patent and Trademark Office released new guidance earlier this year that appears to have somewhat reversed the trend of increased patentable subject matter ineligibility for bioinformatics patent applications.

    Aug 5, 2019
  • CRISPR Patents, Oxford Nanopore, Komodo Dragons, And More: News From July 2019

    Bio-IT World | July featured exciting news, products, and partnerships from around the bio-IT community including CRISPR patents, Oxford Nanopore, the first high-resolution sequence of the Komodo dragon, and more.

    Jul 31, 2019
  • How PetaGene 'Nailed It' With Their PetaSuite Protect

    Bio-IT World | With the rapid growth of genomic data and the need for access by cross-functional teams, it is vital to ensure that this sensitive data is adequately protected and monitored. PetaGene's PetaSuite Protect ensures that protection.

    Jul 29, 2019
  • Novo Nordisk: Natural Language Processing On A Steady Diet Of Real-World Data

    Bio-IT World | Natural language processing is finding novel applications at Novo Nordisk, turning a trio of real-world data sources into a goldmine of knowledge about the medicines it makes, the healthcare providers who prescribe them, and patients who usually pay for a portion of the cost.

    Jul 29, 2019
  • «
  • 271
  • 272 (current)
  • 273
  • 274
  • 275
  • 276
  • 277
  • 278
  • 279
  • 280
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy